Novartis Q3 Results and Pipeline Progress
Novartis, an innovative medicines company, delivers solid sales and core operating income growth with strong pipeline progress in Q3 and reaffirms FY 2025 guidance.
Our mission is to reimagine medicine to improve and extend people’s lives, empowering patients, healthcare professionals, and societies in the face of serious disease. Our medicines reach 296 million people worldwide.
Resources and Information
- Information for patients and their caregivers: clinical trial recruiting, managed access programs, funding opportunities for patient organizations, and side effects reporting.
- Resources for physicians and other healthcare professionals: clinical trial recruiting, grant funding, congresses, and country-level information.
Our Commitment
Discover how Novartis turns breakthrough science into transformative, high-value treatments and learn about our commitments to making a positive impact on the world.
We work to provide access to innovative medicines, protect the environment, and uphold high ethical standards.
Explore the Novartis in Society Integrated Report to learn more about our environmental, social, and governance initiatives.
Author's summary: Novartis delivers strong Q3 results.
More News
- I didn’t miss the irony of Invisible Disabilities Week going unnoticed
- Adam's Anecdote: Leave it to Leavitt for media mishandling
- Adam's Anecdote: Politics are heating up and boiling over
- Is Education Still the Path to Prosperity — or Just an Elaborate Theatre?The Shillong Times
- Karoline Leavitt dishes out lies and insults at the White House – Baptist News Global